Share

Endocrine Society Applauds Eli Lilly’s Efforts to Lower Insulin Costs

Monthly price caps should be available to everyone who depends on insulin The Endocrine Society commends Eli Lilly and Company for taking steps to reduce insulin prices and make insulin affordable for more people with diabetes. Eli Lilly’s announcement to cut insulin prices by 70% and extend the $35 per month insulin cap to people...
Share

Endocrine Society Praises State of the Union Attention to Insulin Affordability

Society calls on Congress to take urgent action to save lives, improve health The Endocrine Society applauds President Biden’s call to rein in soaring insulin prices for those with private insurance and urges Congress to take immediate action. Biden plans to highlight the need for insulin affordability during tonight’s State of the Union address. He...